The drug, known as RHB-107 or Upamostat, has "demonstrated antiviral and potential tissue-protective effects." More than 300 will take part in the trial.
WKYC would like to send you push notifications about the latest news and weather.
Notifications can be turned off anytime in the browser settings.
